| 000 | 00935 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250510211317.0 | ||
| 264 | 0 | _c19791017 | |
| 008 | 197910s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/s0140-6736(79)91476-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGore, M | |
| 245 | 0 | 0 |
_aIntrathecal cytarabine in multiple sclerosis. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cJul 1979 |
||
| 300 |
_a204 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Letter | ||
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aCytarabine _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Spinal |
| 650 | 0 | 4 |
_aMultiple Sclerosis _xdrug therapy |
| 700 | 1 | _aBuckman, R | |
| 700 | 1 | _aStern, G | |
| 773 | 0 |
_tLancet (London, England) _gvol. 2 _gno. 8135 _gp. 204 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(79)91476-4 _zAvailable from publisher's website |
| 999 |
_c87311 _d87311 |
||